Harmonic Director Sold 4,300 Shares: What It Signals for Investors
When a Harmonic director sold 4,300 shares, it sparked questions about the stock’s outlook. This guide breaks down in...
Why Beginners Choose Index Funds
Beginners often choose index funds for broad diversification and low maintenance. This piece explains the primary benefits and how to start with a first fund.
22,044 articlesBitcoin Falls 2-Month After Strategy Sells BTC, ETFs
A strategic BTC sale and easing ETF inflows pushed Bitcoin to a two-month low. This article breaks down what happened...
Navitas Semiconductor Stock Soared: Why It Jumped Today
Navitas Semiconductor carved out a standout session as investors reassessed growth catalysts in power semiconductors....
Kalshi Seeks $40B Valuation Amid Crypto Market Shakeup
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...
Forget Anthropic IPO: These Stocks Could Benefit First
Anthropic’s IPO path is shaping AI headlines, but patient investors can still win by focusing on established tech gia...
Warren Buffett's Rule Dealing: Crash-Proof Investing
Stock crashes test nerves and portfolios. This article breaks down Warren Buffett's rule dealing with crashes and sho...
Shia Labeouf Arrested Punching: Personal Finance Reality
A viral incident can change how people see you—and how money moves. This article uses the moment around shia labeouf ...
Crescent Capital (CCAP) Earnings: Investor Guide 2026
Crescent Capital BDC offers a high-yield opportunity along with risks linked to debt investments. This guide breaks d...
Tax Guide: Treatment Pass-Through Business Sector Basics
Many small businesses run as pass-through entities. This primer explains how the treatment pass-through business sect...
This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Medicare Beneficiaries Hoping GLP-1 Coverage for Weight Loss
A policy push to cover GLP-1 drugs for weight loss under Medicare stalled, leaving many beneficiaries in the middle. ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status